Dr. Carl Edward Thornblade, MD

Dr. Thornblade practices at Montana Allergy Practice in Missoula, Montana.

Dr. Thornblade's NPI, 1073605200, was assigned on September 28, 2006. Dr. Thornblade graduated from University of Pittsburgh School of Medicine in 1997. Dr. Thornblade holds Montana license 11594.

Dr. Thornblade's primary practice is Montana Allergy Practice, at 2801 Great Northern Loop Suite 101 Suite 101, Missoula, MT 59808-1745. The practice phone is (406) 728-6472.

Dr. Thornblade's primary practice is Montana Allergy Practice in Missoula, Montana. The medical group on file is Montana Allergy and Asthma Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thornblade practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Thornblade's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Thornblade is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Thornblade's licenses on file in 3 states: Montana, Maryland and Pennsylvania.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis and hives among the conditions Dr. Thornblade treats.

CMS data shows 12,895 Medicare services from Dr. Thornblade across 15 procedure codes in 2024, for 205 Medicare patients. Medicare paid $246,821 for them. Every service was in an office.

CMS counts 205 Medicare patients who saw Dr. Thornblade in 2024. The largest group is 65 to 74, with 119 patients. 53% of them have high cholesterol, and 50% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.76, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Thornblade's median patient age at 61, with 59% women.

In 2024, Dr. Thornblade wrote 368 Medicare Part D claims for 82 patients. 37% of them were for generic drugs. CMS names the drug for 288 of them, across 13 drugs with 11 or more claims each, at $221,482 in total drug cost. In 2023, CMS named 170 claims across 7 drugs.

Dr. Thornblade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Thornblade to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Vitiligo and Chronic Urticaria. Open Payments lists research payments to Dr. Thornblade that name 1 trial.

CMS Open Payments shows 445 general payments to Dr. Thornblade from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 36% of the total. Pharming Healthcare, Inc. paid the most, $8,739. It also lists 24 research payments totaling $17,228 from 2016 to 2024, naming 1 clinical trial.

Dr. Thornblade graduated from University of Pittsburgh School of Medicine in 1997. Dr. Thornblade is a member of AAAAI, ACAAI and Intermountain West Allergy Association.

Dr. Thornblade is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.